A noninvasive way of screening newborns for Gaucher disease, using dried blood spots, is both efficient and feasible, according to…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Researchers suggest that a compound called ambroxol should be explored in clinical trials as a potential drug for Gaucher disease.
Genetic screening for Gaucher disease identifies many patients that may never experience symptoms, according to a new study, and researchers…
Making lysosomes more acidic may be an ingeniously simple, yet efficient, way to prevent the consequences of lysosomal storage disorders…
Imiglucerase (Cerezyme) has an excellent track record in treating type 1 Gaucher disease, according to a recent review that analyzed…
Researchers from New York University School of Medicine recently found that treating a mouse model of Gaucher disease with a key…
A case of a woman with Gaucher disease who was also diagnosed with systemic lupus erythematosus has raised questions about whether…
A recent review of substrate reduction therapy for Gaucher disease, by the National Health Institute Doutor Ricardo Jorge, in Portugal, explored…
A case report by researchers at Chacha Nehru Bal Chikitsalya Hospital in India described a child with a rare…